Sabejon, Lita D.

HRN: 14-36-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2026
CEFTRIAXONE 1G (VIAL)
06/12/2026
06/19/2026
IV
2G
OD
CAP-MR; UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: